grouP O wholE blooD : storagE leSion impacT And infLammation

Recruiting N/A Interventional Study
Blood Donation Blood Platelets Blood Donors Inflammation Transfusion
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
30 (estimated)
Sponsor
Etablissement Français du Sang · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
"Etablissement Français du Sang" (EFS) prepares labile blood products from blood donations that are separated by type (red blood cells, plasma and platelets). The "Centre de Transfusion Sanguine des Armées" (CTSA) produces an innovative labile blood product, LTO-WB, corresponding to group O leukocyte-free whole blood. The objective of the PEDESTAL EFS study is to compare the inflammatory and bio…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Self-referred donors eligible for blood donation (whole blood and/or platelet/plasma apheresis), meeting the following inclusion criteria: * Be in good health * Weigh at least 50 kg * Must be between 18 and 70 years of age for whole blood donation and between 18 and 65 years of…
Contacts

Hind HAMZEH-COGNASSE, PhD, HDR

+33 477 421 400

hind.hamzeh@univ-st-etienne.fr

CONTACT

Fabrice COGNASSE, PhD, HDR

+33 683 975 883

fabrice.cognasse@efs.sante.fr

CONTACT